Study of Venus P-Valve for lung valve problems
Part of Heart & circulation clinical trials.
This observational study follows people who need a pulmonary valve treatment, to see how the Venus P-Valve works in real-world care. It may help doctors understand which patients benefit and how outcomes change over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have your own right-ventricular outflow tract (RVOT), even if you previously had a patch repair
- You have moderate or worse pulmonary regurgitation (lung valve leaking), with or without pulmonary stenosis (narrowing)
- Your clinician says you need a pulmonary valve intervention
- You (or your legal representative) agree to join the study
- You can commit to attending follow-up visits and completing the study checks
- No medical issue that would block use of the Venus P-Valve instructions for use or make you unable to follow the study plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new less-invasive heart valve (VenusP-Valve) for people whose own pulmonary valve is leaking severely. If you qualify, you could get the new valve without open-heart surgery.
This study follows patients who received the VenusP-Valve™ System (an artificial heart valve) 6–10 years ago to check how well it's working over time and ensure it remains safe.
This study looks at a new device called the PULSTA Transcatheter Pulmonary Valve, which is placed without open-heart surgery to help people with a leaky or narrowed pulmonary valve. It aims to see how well the valve works over time.
This study tests an early, first-use version of a new pulmonary valve device for children whose own valve is not working well. It may help improve blood flow from the heart to the lungs and aims to learn how safe and effective the valve is over time.
This trial studies a transcatheter pulmonary valve (a valve placed through a catheter) in people whose right-sided outflow tract valve/conduit is not working well. It aims to improve blood flow and reduce pressure problems, while checking safety and results after the procedure.
This trial tests a new heart valve device (Venus-Vitae) for people with severe aortic stenosis, a condition where the heart valve is too tight. It aims to see if the device works well for patients of all surgical risk levels.
Hear when a new Right Ventricular Outflow Tract Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.